Sydney Lupkin
speaker
1,087 appearances
111 recordings
3 series
first heard Dec 2024
last heard 2d ago
Sydney Lupkin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 96 in all, peaking in Sep 2026 with 23.
Appearances
Eli Lilly's experimental new drug is called retitrutide.
It's still being studied and hasn't yet been submitted to the Food and Drug Administration for approval, but new study results show that patients taking the highest dose of the drug lost an average of 72 pounds over 68 weeks, according to the company.
Patients in the trial had knee arthritis, and researchers found that the drug also markedly reduced patients' knee pain.
Side effects for retitrutide included nausea, constipation, and vomiting.
Lilly said the results will be presented at a future medical meeting and published in a peer-reviewed journal.
Sydney Lepkin, NPR News.
New drugs typically cost a lot more in the U.S.
than they do in other countries.
And the Trump administration has been announcing deals with drug companies to try to even the playing field.
Now the U.S.
has a deal with another country, the U.K.
The U.K.
will increase the prices its health service pays for new medicines by 25 percent and will reduce rebates paid by drug makers.
That's according to the Office of the United States Trade Representative.
In exchange, U.K.
drugs, drug ingredients, and medical technology will be exempt from U.S.
tariffs for at least three years.
Sydney Lupkin, NPR News.
People buying Wagovi directly from Novo Nordisk will now be able to get it for around $350 a month.
Until the end of next March, the company will offer the first two months doses at around $200 a month.
Showing 781–800 of 1,087 · page 40 of 55
← Previous
Next →